CryoPort, Inc.
CYRX
$6.23
-$0.43-6.46%
| Weiss Ratings | CYRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | CYRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CYRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.61 | |||
| Price History | CYRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 4.71% | |||
| 30-Day Total Return | -25.12% | |||
| 60-Day Total Return | -15.01% | |||
| 90-Day Total Return | -7.57% | |||
| Year to Date Total Return | -21.93% | |||
| 1-Year Total Return | -64.13% | |||
| 2-Year Total Return | -72.06% | |||
| 3-Year Total Return | -79.96% | |||
| 5-Year Total Return | -64.42% | |||
| 52-Week High % Change | -66.87% | |||
| 52-Week Low % Change | 45.41% | |||
| Price | CYRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $20.11 | |||
| 52-Week Low Price | $4.58 | |||
| 52-Week Low Price (Date) | Mar 04, 2025 | |||
| 52-Week High Price (Date) | Apr 04, 2024 | |||
| Valuation | CYRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 329.21M | |||
| Enterprise Value | 318.16M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -3.39 | |||
| Earnings Per Share Growth | 200.68% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.46 | |||
| Price/Book (Q) | 0.85 | |||
| Enterprise Value/Revenue (TTM) | 1.41 | |||
| Price | $6.23 | |||
| Enterprise Value/EBITDA (TTM) | -7.56 | |||
| Enterprise Value/EBIT | -4.39 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | CYRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 49.42M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CYRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 949 470 2300 | |||
| Address | 112 Westwood Place Brentwood, TN 37027 | |||
| Website | www.cryoportinc.com | |||
| Country | United States | |||
| Year Founded | 1999 | |||
| Profitability | CYRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -32.01% | |||
| Profit Margin | -70.08% | |||
| Management Effectiveness | CYRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -5.32% | |||
| Return on Equity | -- | |||
| Income Statement | CYRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 226.11M | |||
| Total Revenue (TTM) | 226.11M | |||
| Revenue Per Share | $4.58 | |||
| Gross Profit (TTM) | 95.61M | |||
| EBITDA (TTM) | -42.09M | |||
| EBIT (TTM) | -72.40M | |||
| Net Income (TTM) | -158.47M | |||
| Net Income Avl. to Common (TTM) | -158.47M | |||
| Total Revenue Growth (Q YOY) | 0.90% | |||
| Earnings Growth (Q YOY) | 106.07% | |||
| EPS Diluted (TTM) | -3.39 | |||
| EPS Diluted Growth (Q YOY) | 92.25% | |||
| Balance Sheet | CYRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 272.67M | |||
| Cash Per Share (Q) | $5.52 | |||
| Total Current Assets (Q) | 350.34M | |||
| Total Preferred Equity (Q) | 32.28 | |||
| Total Equity (Q) | 418.57M | |||
| Current Ratio (Q) | 5.702 | |||
| Book Value Per Share (Q) | $7.81 | |||
| Total Assets (Q) | 701.77M | |||
| Total Current Liabilities (Q) | 61.44M | |||
| Total Debt (Q) | 233.37M | |||
| Total Liabilities (Q) | 283.19M | |||
| Total Common Equity (Q) | 386.30M | |||
| Cash Flow | CYRX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 158.58M | |||
| Cash from Financing (TTM) | -163.67M | |||
| Net Change in Cash (TTM) | -14.81M | |||
| Levered Free Cash Flow (TTM) | -15.99M | |||
| Cash from Operations (TTM) | -8.36M | |||
